SynopsisRilonacept, sold under the brand name Arcalyst, is a medication used to treat cryopyrin-associated periodic syndromes, including familial cold autoinflammatory syndrome, and Muckle–Wells syndrome; deficiency of interleukin-1 receptor antagonist; and recurrent .....
SynopsisEnbrel is a biopharmaceutical that treats autoimmune diseases by interfering with tumor necrosis factor (TNF, a soluble inflammatory cytokine) by acting as a TNF inhibitor. The global Enbrel market was valued at US$ 8764 million in 2023 and is anticipate.....
SynopsisEtanercept, sold under the brand name Enbrel among others, is a biopharmaceutical that treats autoimmune diseases by interfering with tumor necrosis factor (TNF, a soluble inflammatory cytokine) by acting as a TNF inhibitor. The global Etanercept Drugs m.....
SynopsisALPROLIX® [Coagulation Factor IX (Recombinant), Fc Fusion Protein] is an injectable medicine that is used to help control and prevent bleeding in people with hemophilia B. The global Alprolix market was valued at US$ 897 million in 2023 and is anticipate.....
SynopsisElocta is a medicine used to treat and prevent bleeding in patients with haemophilia A (an inherited bleeding disorder caused by lack of factor VIII). The global Elocta and Eloctate market was valued at US$ 1420 million in 2023 and is anticipated to reac.....
SynopsisFc Fusion Protein can used for haemophilia A and Hemophilia B The global Fc Fusion Protein for Haemophilia market was valued at US$ 2317 million in 2023 and is anticipated to reach US$ 3441.4 million by 2030, witnessing a CAGR of 5.0% during the forecast.....
SynopsisTrulicity (dulaglutide) is a diabetes medication for adults with type 2 diabetes that is injected once a week to help lower blood sugar. The global Trulicity market was valued at US$ 6741 million in 2023 and is anticipated to reach US$ 13270 million by 2.....
SynopsisTrulicity (dulaglutide) is a diabetes medication for adults with type 2 diabetes that is injected once a week to help lower blood sugar. The global Fc Fusion Protein for Diabetes market was valued at US$ 6741 million in 2023 and is anticipated to reach U.....
SynopsisFc Fusion Protein can used for eye disease. The global Fc Fusion Protein for Eye Diseases market was valued at US$ 9970 million in 2023 and is anticipated to reach US$ 23370 million by 2030, witnessing a CAGR of 12.9% during the forecast period 2024-2030.....
SynopsisAn autoimmune disease is a condition arising from an abnormal immune response to a functioning body part. There are at least 80 types of autoimmune diseases. Nearly any body part can be involved. Common symptoms include low grade fever and feeling tired. Often.....
